The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
The rise of the genome and personalised medicine
Open accessAbstract
Abstract Virtually all medical specialties are impacted by genetic disease. Enhanced understanding of the role of genetics in human disease, coupled with rapid advancement in sequencing technology, is transforming the speed of diagnosis for patients and providing increasing opportunities to tailor management. As set out in the Annual report of the Chief Medical Officer 2016: Generation Genome1 and the recent NHS England board paper Creating a genomic medicine service to lay the foundations to deliver personalised interventions and treatments,2 the increasing ‘mainstreaming’ of genetic testing into routine practice and plans to embed whole genome sequencing in the NHS mean that the profile and importance of genomics is on the rise for many clinicians. This article provides a brief overview of genomics and its current clinical applications, including its contribution to personalised medicine. Physicians will be signposted to key issues that will allow the successful implementation of genomics for rare disease diagnosis and cancer management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594
Improved survival with vemurafenib in melanoma with BRAF V600E mutation
Chapman, P. B., Hauschild, A., Robert, C., Haanen, J. B., Ascierto, P., Larkin, J., Dummer, R., Garbe, C., Testori, A., Maio, M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103782 · Cited by 7,720
Cited by
Pan-cancer circulating tumor DNA detection in over 10,000 Chinese patients
Zhang, Y., Yao, Y., Xu, Y., Li, L., Gong, Y., Zhang, K., Zhang, M., Guan, Y., Chang, L., Xia, X., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20162-8 · Cited by 300
Ki-67 as a Prognostic Biomarker in Invasive Breast Cancer
Davey, M. G., Hynes, S. O., Kerin, M. J., Miller, N., & Lowery, A. J. (2021) · Cancers · doi:10.3390/cancers13174455 · Cited by 298
Process mining for healthcare: Characteristics and challenges
Munoz-Gama, J., Martin, N., Fernandez-Llatas, C., Johnson, O. A., Sepúlveda, M., Helm, E., Galvez-Yanjari, V., Rojas, E., Martinez-Millana, A., Aloini, D., et al. (2022) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2022.103994 · Cited by 287
Vijayakumar, S., Lee, V. V., Leong, Q. Y., Hong, S. J., Blasiak, A., & Ho, D. (2023) · JMIR Human Factors · doi:10.2196/48476 · Cited by 34
Reliable machine learning models in genomic medicine using conformal prediction
Papangelou, C., Kyriakidis, K., Natsiavas, P., Chouvarda, I., & Malousi, A. (2025) · Frontiers in Bioinformatics · doi:10.3389/fbinf.2025.1507448 · Cited by 12
Metadata
- Authors
- Brittain, H. K., Scott, R., & Thomas, E.
- Venue
- Clinical Medicine
- Publisher
- Elsevier BV
- Published
- 2017-12
- Volume
- 17
- Issue
- 6
- Pages
- 545-551
- ISSN
- 1470-2118 (ISSN-L)
- OpenAlex
- W2773318670
- Cited by
- 201
- References
- 2
- FWCI
- 2.45
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The rise of the genome and personalised medicine. https://app.cochat.ai/papers/10.7861/clinmedicine.17-6-545
- The paper
- Brittain, H. K., Scott, R., & Thomas, E. (2017). The rise of the genome and personalised medicine. Clinical Medicine. https://doi.org/10.7861/clinmedicine.17-6-545
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.